Accepted for Publication: February 23, 2021.
Published Online: April 14, 2021. doi:10.1001/jamadermatol.2021.0734
Corresponding Author: Mona Ståhle, MD, B2:01, Division of Dermatology and Venereology, Department of Medicine, Karolinska Universitetssjukhuset, Solna 171 76 Stockholm, Sweden (email@example.com).
Author Contributions: Mr Svedbom and Dr Ståhle had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Larsson, Lindqvist, Ståhle.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Svedbom, Ståhle.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Svedbom.
Obtained funding: Ståhle.
Administrative, technical, or material support: Nikamo, Wolk, Kjellman, Eidsmo, Lindqvist, Ståhle.
Supervision: Lindqvist, Ståhle.
Conflict of Interest Disclosures: Mr Svedbom is an employee of ICON Clinical Research, a contract research organization. Dr Mallbris is an employee of Eli Lilly and Company. Dr Ståhle has consulting agreements involving financial compensation with Eli Lilly and Company, AbbVie, Janssen, Leo Pharma, BMS, and Novartis. No other disclosures were reported.
Funding/Support: This study was funded by the Stockholm County Council, the Swedish Medical Research Council, Hudfonden, and the Swedish Psoriasis Association.
Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank the pictured patients for granting permission to publish this information. We are also grateful to the patients for participating, Eva Vingård, PhD (Department of Medical Science, Uppsala University), for input on the clinical research forms, and Maria Lundqvist, BS, and Susanne Bergqvist, BS (Department of Dermatology Karolinska University Hospital), for supporting study operations.
WHO. Global Report on Psoriasis. World Health Organization;2016.
BE , Griffiths
CE , O’Dell
SJ , Tebbey
PW , Barker
JN ; International Psoriasis Council. Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise. Br J Dermatol
. 2016;174(1):212-215. doi:10.1111/bjd.13980
B , Hammar
N , Fored
et al. The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf
. 2007;16(7):726-735. doi:10.1002/pds.1294
E , Sterry
W. Psoriasis. In: Fitzpatrick TB, Elsen AZ, Wolff K, Freedberg IM Austen KF, eds. Dermatology in General Medicine. 4th ed. McGraw-Hill; 1993:489-514.
B , Holmström
G , Lindqvist
U ; Psoriatric Arthritis Register Group of the Swedish Society for Rheumatology. Development and early experiences of a Swedish psoriatic arthritis register. Scand J Rheumatol
. 2002;31(4):221-225. doi:10.1080/030097402320318413
W , Gladman
D , Helliwell
P , Marchesoni
A , Mease
P , Mielants
H ; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum
. 2006;54(8):2665-2673. doi:10.1002/art.21972
P , Lysell
J , Ståhle
M . Association with genetic variants in the IL-23 and NF-κB pathways discriminates between mild and severe psoriasis skin disease. J Invest Dermatol
. 2015;135(8):1969-1976. doi:10.1038/jid.2015.103
D , Eriksson
M , Sundström
A , Schmitt-Egenolf
M . The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PLoS One
. 2013;8(5):e63619. doi:10.1371/journal.pone.0063619
L , Polachek
A , Rosen
CF , Chandran
V , Cook
R , Gladman
DD . The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort Study. Arthritis Rheumatol
. 2017;69(3):622-629. doi:10.1002/art.39973
FC , Icen
M , Crowson
CS , McEvoy
MT , Gabriel
SE , Kremers
HM . Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum
. 2009;61(2):233-239. doi:10.1002/art.24172
A . Psoriasis and psoriatic arthritis treatment. Am J Manag Care
. 2016;22(8)(suppl):s225-s237.PubMedGoogle Scholar